Skip to main content
. 2025 Nov 7. Online ahead of print. doi: 10.1039/d5md00787a

Table 2. MG-MID (μM) values of compounds 4a–4d, 6a–6c, 6f, 6h, and 6i on a subpanel of cancer cell lines.

Subpanel Compound ID
4a 4b 4c 4d 6a 6b 6c 6f 6h 6i
MG-MIDa (μM)
Leukemia 1.657 2.220 0.996 2.414 7.822 7.445 1.530 2.067 1.910 5.415
Non-small cell lung cancer 5.240 3.483 2.519 6.940 15.856 28.275 8.471 5.267 5.947 8.102
Colon cancer 3.537 3.024 1.405 3.487 12.607 14.736 4.919 3.336 3.087 7.397
CNS cancer 5.027 4.210 2.773 5.698 11.365 16.865 3.408 2.940 4.197 5.698
Melanoma 4.089 3.684 1.721 5.939 13.101 17.893 3.564 4.680 3.667 5.643
Ovarian cancer 5.756 3.271 3.403 6.369 13.694 23.720 8.856 6.349 9.867 8.533
Renal cancer 5.966 3.560 1.983 8.907 14.167 33.783 8.345 5.510 4.876 12.126
Prostate cancer 4.060 6.900 1.940 3.570 17.400 61.300 12.400 6.200 2.415 10.685
Breast cancer 3.478 2.378 1.621 4.458 10.427 15.775 1.698 2.167 2.855 5.475
Full panel MG-MIDb 4.312 3.637 2.040 5.309 12.938 24.421 5.910 4.279 4.313 7.675
a

Median value of GI50 (μM) calculated according to the data obtained from NCI's tumor cell screen.

b

Full panel mean graph midpoint (MG-MID) is the average sensitivity of all cell lines towards the tested compounds.